BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 15556624)

  • 1. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
    Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
    FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
    J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX.
    Hulikova A; Zatovicova M; Svastova E; Ditte P; Brasseur R; Kettmann R; Supuran CT; Kopacek J; Pastorek J; Pastorekova S
    FEBS Lett; 2009 Nov; 583(22):3563-8. PubMed ID: 19861127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
    Ditte P; Dequiedt F; Svastova E; Hulikova A; Ohradanova-Repic A; Zatovicova M; Csaderova L; Kopacek J; Supuran CT; Pastorekova S; Pastorek J
    Cancer Res; 2011 Dec; 71(24):7558-67. PubMed ID: 22037869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors.
    Dubois L; Douma K; Supuran CT; Chiu RK; van Zandvoort MA; Pastoreková S; Scozzafava A; Wouters BG; Lambin P
    Radiother Oncol; 2007 Jun; 83(3):367-73. PubMed ID: 17502120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates.
    Rami M; Dubois L; Parvathaneni NK; Alterio V; van Kuijk SJ; Monti SM; Lambin P; De Simone G; Supuran CT; Winum JY
    J Med Chem; 2013 Nov; 56(21):8512-20. PubMed ID: 24128000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
    Ihnatko R; Kubes M; Takacova M; Sedlakova O; Sedlak J; Pastorek J; Kopacek J; Pastorekova S
    Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
    Pastorek J; Pastorekova S
    Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.
    Rogez-Florent T; Meignan S; Foulon C; Six P; Gros A; Bal-Mahieu C; Supuran CT; Scozzafava A; Frédérick R; Masereel B; Depreux P; Lansiaux A; Goossens JF; Gluszok S; Goossens L
    Bioorg Med Chem; 2013 Mar; 21(6):1451-64. PubMed ID: 23168081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
    J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.
    Rafajová M; Zatovicová M; Kettmann R; Pastorek J; Pastoreková S
    Int J Oncol; 2004 Apr; 24(4):995-1004. PubMed ID: 15010840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
    Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of carbonic anhydrase IX to 45S rDNA genes is prevented by exportin-1 in hypoxic cells.
    Sasso E; Vitale M; Monteleone F; Boffo FL; Santoriello M; Sarnataro D; Garbi C; Sabatella M; Crifò B; Paolella LA; Minopoli G; Winum JY; Zambrano N
    Biomed Res Int; 2015; 2015():674920. PubMed ID: 25793203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
    Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Dynamics of CA IX Epitope in Cancer Cells under Intermittent Hypoxia Correlates with Extracellular pH Drop and Cell Killing by Ureido-Sulfonamide CA IX Inhibitors.
    Sufian MA; Zamanova S; Shabana AM; Kemp B; Mondal UK; Supuran CT; Ilies MA
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
    Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D
    J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.